Document: Timetable: Post-authorisation safety study (PASS) protocols and final results-2025/9/23

Document: Timetable: Periodic safety update report (PSUR) and PSUR single assessment (PSUSA)-2025/9/23

Document: Timetable: Periodic safety update report (PSUR) and PSUR single assessment (PSUSA) - Advanced therapy medicinal products (ATMPs)-2025/9/23

Document: Start of procedure: Type II variation - Extension of indication under evaluation by the CHMP (22 August 2025 - 18 September 2025)-2025/9/23

Document: Request to the CVMP for classification of a veterinary medicinal product as intended for a limited market according to Article 4(29) and for eligibility for authorisation according to Article 23 (Applications for limited markets)-2025/9/23

Document: Engineered living materials for in situ production of therapeutics - EU-IN Horizon Scanning Report-2025/9/23

Document: List of medicinal products under additional monitoring-2025/9/23

Document: List of medicinal products under additional monitoring-2025/9/23

Document: MedDRA important medical event terms list - version 28.1-2025/9/23

Page: Guidance on the application of the revised variations framework-2025/9/22